个人简介

Education Ph.D. University of Toronto M.D. University of Toronto Academic and Professional Experience 2015-present Adjunct Distinguished Professor, Faculty of Health Sciences, University of Macau 2014-2015 Distinguished Professor, Faculty of Health Sciences, University of Macau

研究领域

Immune thrombocytopenia Leukemia, Myelodysplastic syndrome Thombosis, Transfusion medicine

Patents Transfusion wristband to improve transfusion safety

近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Representative Publications Gregory Cheng, Mansoor N. Saleh, Claus Marcher, Sandra Vasey, Bhabita Mayer, Manuel Aivado, Michael Arning, Nicole L. Stone, James B. Bussel. Eltrombopag for the Management of Chronic Immune Thrombocytopenia: a 6-month, Randomised, Phase III Study (RAISE). Lancet. 2011 Jan 29;377(9763):393-402. Yunfeng Cheng, Raymond S.M. Wong, Yannie O.Y. Soo, Chung Hin Chui, Fung Yi Lau, Natalie P.H. Chan, Wai Shan Wong, Gregory Cheng. Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose Dexamethasone. NEJM 2003 Aug; 349:831-836. Bussel J. B., Cheng G., Saleh M.N., Psaiia B., Kovaleva L., Meddeb B., Kloczko J., Hassani H., Mayer B., Stone N.L., Arning M., Provan D., Jenkins J.M. Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura. NEJM 2007 Nov; 357: 2237-47. Bussel B J; Provan D; Shamst T; Cheng Gregory; Psaila B; Kovaleva L; Salama A; Jenkins M J; Roychowdhury D; Mayer B; Stone N and Arning M. “Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.” Lancet vol.373 no.9664, pp.641-8. 2009.02.21. Yunfeng Cheng, Gregory Cheng, CH Chui, FY Lau, Paul KS Chan, Margaret HL Ng, Joseph JY Sung, Raymond SM Wong. ABO Blood Group and Human Susceptibility to SARS. JAMA Vol. 293, no. 12:1450-51, 2005 Mar 05. Kok Hon Lung Stanton; Wong Siu Ming Raymond; Gambari Roberto; Kok Hon Lung Stanton; Cheung Filly; Lam Wing Sze; Lau Fung Yi; Cheng Gregory; “In vitro cytotoxicity of (-)-EGCG octaacetate on MDAMB-231 and SKHep-1 human carcinoma cells: a pharmacological consideration on prodrug design.”. International Journal of Molecular Medicine vol.22 no.6, pp.841-845. 2008.12. Cheng, G. Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?. Clinical Investigation 2015,5,3, 287-296.

学术兼职

Council Member  HK Association of Blood Transfusion & Haematology  Council Member  Leukaemia Patient Support Group